Droplet Digital PCR Partitioning for High-Plex Nucleic Acid Detection

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing PCR methods struggle with high-throughput multiplexing due to limited spectral resolution of fluorophores, thermodynamic inefficiencies, and primer/probe optimization challenges, leading to stochastic sampling bias and false positives in nucleic acid analysis, especially in low-abundance mutations.

Innovation Solution

Droplet-based digital PCR (dPCR) using microfluidic droplets containing a single nucleic acid template and multiple primer pairs, with optically labeled probes for simultaneous amplification and detection, allowing for precise analysis of multiple targets without allele-specific competition.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Adaptability or versatility

If traditional qPCR methods are used for multiplexing, then detection capability is improved, but spectral resolution limits the multiplexing capacity to 4x

Engineering Contradiction:
Improvemultiplexing capacityVSAvoidspectral resolution requirements
Core Design Contradiction:
Adaptability or versatilityVSDevice complexity

Solution Approach 1:

The patent divides the sample into multiple separate reactions (digital partitioning), where each reaction contains a single template molecule. This segmentation allows each reaction to be analyzed independently, eliminating the spectral overlap problem that limits traditional multiplexing and enabling detection of multiple targets without requiring complex spectral resolution.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The patent transitions from analyzing multiple targets simultaneously in a single reaction (spectral dimension) to analyzing multiple reactions in parallel (reaction number dimension). By moving to digital PCR with individual reactions for each target, the system achieves high multiplexing capacity through parallel reaction analysis rather than spectral multiplexing.

Inventive Principle:
Principle #17Another dimension (Dimensionality change)

2Productivity

If multiple primer/probe reactions are combined for multiplexing, then throughput is improved, but thermodynamic efficiencies and chemical kinetics change requiring extensive optimization

Engineering Contradiction:
ImprovethroughputVSAvoidreaction optimization
Core Design Contradiction:
ProductivityVSEase of manufacture

Solution Approach 1:

By partitioning the sample into individual reactions with single template molecules, the patent eliminates primer-probe interactions between different targets. Each reaction's thermodynamics and kinetics remain independent and unchanged from single-plex conditions, removing the need for extensive multiplex optimization while maintaining high throughput through parallel reaction analysis.

Inventive Principle:
Principle #1Segmentation

3Measurement precision

If dilute samples are divided into many separate reactions for digital PCR, then quantitation precision is improved, but DNA consumption increases

Engineering Contradiction:
Improvequantitation precisionVSAvoidDNA consumption
Core Design Contradiction:
Measurement precisionVSLoss of substance

Solution Approach 1:

The patent uses limiting dilution where most reactions contain zero or one template molecule, avoiding excessive DNA input. By analyzing only the positive reactions (those with template) and using Poisson statistics, the method achieves precise quantitation with minimal DNA consumption, as unnecessary amplifications are avoided.

Inventive Principle:
Principle #16Partial or excessive action

4Adaptability or versatility

If end-point PCR is used for high amplicon multiplexing, then multiplexing capacity is improved, but quantitative accuracy deteriorates

Engineering Contradiction:
Improvemultiplexing capacityVSAvoidquantitative accuracy
Core Design Contradiction:
Adaptability or versatilityVSMeasurement precision

Solution Approach 1:

The patent combines the high multiplexing capacity of end-point PCR with quantitative accuracy by segmenting the sample into individual reactions and counting positive reactions. This digital counting approach eliminates the need for end-point fluorescence interpretation, providing both high multiplexing capability and precise quantitation through statistical analysis of reaction positivity.

Inventive Principle:
Principle #1Segmentation

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

Enables high-plex PCR reactions with reduced DNA consumption, improved sensitivity, and accurate detection of multiple targets, including haplotypes, by eliminating stochastic bias and false positives.

Implementation Method 1

The template is amplified in the droplet for detection; and may preferably be amplified using a plurality of primer pairs as described herein

Methodology Applied
Scientific EffectPCR amplification: Enzyme

Implementation Method 2

with optically labeled probes for simultaneous amplification and detection

Methodology Applied
Scientific EffectFluorescence: Fluorescence

Data Source

PatentUS12351860B2Digital analyte analysis
Publication Date: 2025.07.08 BIO RAD LABORATORIES INC
  • US12351860B2 patent drawing
  • US12351860B2 patent drawing
  • US12351860B2 patent drawing

AI summary

The invention generally relates to droplet based digital PCR and methods for analyzing a target nucleic acid using the same. In certain embodiments, methods of the invention involve forming sample droplets containing, on average, a single target nucleic acid, amplifying the target in the droplets, excluding droplets containing amplicon from the target and amplicon from a variant of the target, and analyzing target amplicons.